General description
INN
Everolimus
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2021
(TRS
1035)
for
Other specified gliomas of brain
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
- Oral > Solid: 2.5 mg; 5 mg; 7.5 mg; 10 mg; 2 mg tablet (dispersible); 3 mg tablet (dispersible); 5 mg tablet (dispersible)
Indications